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A report on the 29th Lorne Genome Conference on the
Organization and Expression of the Genome, Lorne,
Australia, 17-21 February 2008.
The Lorne Genome conference is held annually in the
historic seaside town of Lorne on the southern Australian
coast. This year’s meeting showcased a broad range of topics,
including chromatin structure, epigenetic memory, trans-
criptional regulation and the role of noncoding small RNAs
in gene silencing. Here we report on some of the highlights
of the meeting.
C Ch hr ro om ma at ti in n   d dy yn na am mi ic cs s   a an nd d   t tr ra an ns sc cr ri ip pt ti io on n   r re eg gu ul la at ti io on n
There is now strong evidence for the role of noncoding RNA,
particularly microRNA (miRNA), in establishing and main-
taining the transcriptional state of the chromatin. Michael
Axtell (Pennsylvania State University, University Park, USA)
described new molecular and computational biology tech-
niques to screen for novel small RNAs and their functions in
plants. He and his colleagues applied high-throughput
‘degradome’ sequencing and directly identified miRNA
targets using experimental data. In addition, they recognized
molecular functions for several other types of small RNAs in
various plant species. Interestingly, they showed that diverse
miRNA sequences from different plant species can perform
common biological functions.
Posttranslational modifications of histones form the histone
code that modulates transcription by affecting histone-DNA
interactions and recruiting other transcriptional activator and
repressor proteins. One of the more memorable talks at the
meeting concerned chromatin organization and modification
by David Allis (Rockefeller University, New York, USA). Allis
described how effector proteins have the capacity to recognize
histone tail posttranslational modifications through protein
motifs such as the bromodomains that specifically recognize
acetylated lysine residues. In particular, he described how
certain PHD finger domains, which bind specifically to
trimethylated lysine marks on histone H3, have recently been
identified as ‘readers’ of this mark. It is generally thought that
such motifs recognize posttranslational modification and
create a network of interactions that decipher the histone
code. Importantly, however, Allis also discussed recent
questioning of the validity of a simple one-mark-to-one-
module type of decoding and the need for a modified histone
code hypothesis that can accommodate both observations that
multiple binding partners have been reported for a single
histone, and that bromodomains are promiscuous with regard
to the sequence context of substrate acetylation marks. He
proposed the “phenomenon of multivalency, in which the
cooperative engagement of several linked substrates by a
species with more than one discrete interaction surface” may
be a common mechanism in chromatin transactions and
account for the above issues “without abandoning the core of
the original histone code hypothesis.”
Kenneth Zaret (Fox Chase Cancer Center, Philadelphia,
USA) reported an interesting mechanism whereby chroma-
tin opening by ‘pioneering’ transcription factors precedes
histone modifications during tissue-specific gene activation.
He and colleagues established the ability of the FOXA trans-
cription factors to recognize highly compact silent genes that
have the potential to be activated in developing liver cells.
They showed that FOXA factors have non-sequence-specific,
intrinsic binding capacity to highly condensed chromatin
and are able to expose the underlying DNA. They used the
fluorescence recovery after photobleaching (FRAP) tech-
nique to demonstrate that FOXA factors may laterally scan
along the chromatin and serve as an epigenetic mark to
indicate chromatin identity and potential activity. Indeed,
the notion that transcription factors themselves can serve as
critical epigenetic marks has been lost with the excitement of
the histone code hypothesis.Steve Smale (University of California, Los Angeles, USA)
provided a functional support for such pioneering trans-
cription factors in the transcriptional activation of tissue-
specific genes in differentiating embryonic stem (ES) cells.
He reported the presence of selective unmethylated regions
in the enhancers of well-defined tissue-specific genes that
are maintained as unmethylated in ES cells owing to the
binding of specific pioneering transcription factors. Erasure
of these enhancer marks in differentiated cells led to
assembly of repressive chromatin structures that were
resistant to decondensation. The data suggest that these
enhancer marks in ES cells are important for subsequent
transcriptional activation of genes in differentiated tissues.
Continuing with the theme of regulatory changes in the
composition of chromatin, Robert Kingston (Harvard
Medical School, Boston, USA) described a new technology
for isolating locus-specific chromatin and associated inter-
acting proteins. He has used a modified fluorescent in situ
hybridization protocol to isolate human telomere-specific
chromatin. He and his colleagues compared telomeres from
HeLa cells with those from cancer cells that employ
alternative lengthening of telomeres (ALT) and discovered a
family of orphan nuclear receptors that bind specifically to
ALT telomeres. Kingston reported that the interaction with
these proteins is required for mediating the recombination
needed to maintain ALT telomeres.
C Ca an nc ce er r   g ge en no om mi ic cs s
Molecular events underlying gene regulation in cancer were
the major focus of talks given by Susan Clark (Garvan
Institute for Medical Research, Sydney, Australia) and David
Bowtell (Peter MacCallum Cancer Centre, Melbourne,
Australia). Clark focused on understanding the interplay
between DNA methylation and chromatin modifications and
their contribution to aberrant gene expression in cancers.
She described a genome-wide screen for differential DNA
methylation aimed at identifying patterns of CpG hyper-
methylation in colorectal cancer samples. In this study she
identified a novel mechanism for epigenetic gene silencing
involving coordinated silencing of large regions of chromo-
somes, which ensures the simultaneous suppression of
numerous genes regardless of their individual methylation
status. Many cancer epigenome studies have focused on
locus-specific changes, but Clark’s work emphasizes the fact
that the global consequences of these epigenetic changes
must be considered.
Bowtell described a large cohort study (the Australian
Ovarian Cancer Study) that addresses epidemiological and
genetic aspects of ovarian cancer. He and his colleagues have
carried out genomic analyses of 330 ovarian cancer samples,
profiling regions of chromosomal DNA duplication or loss
and patterns of gene expression. In the process they have
created one of the largest expression datasets for ovarian
cancer so far. From the expression data they were able to
identify four molecular subtypes of high-grade serous and
endometrial cancer, as well as two smaller invasive subtypes
reflective of borderline serous and low-grade endometriod
cancers. They are currently investigating mutations that
drive the development and growth of ovarian tumor subtypes.
R Re eg gu ul la at to or ry y   n ne et tw wo or rk ks s, ,   n nu uc cl le ea ar r   o or rg ga an ni iz za at ti io on n   a an nd d
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Characterization of transcription factor-DNA interactions
into regulatory networks is important for understanding
differential regulation of gene expression. Marian Walhout
(University of Massachusetts Medical School, Worcester,
USA) presented a systematic approach to identifying trans-
cription factor-DNA and factor-factor interactions and
incorporated them into regulatory networks using freely
available Web-based packages. She used a modified yeast
one-hybrid assay to identify transcription factor-DNA inter-
actions between Caenorhabditis elegans gene promoters
and transcription factors, and the networks that connect
them. Conversely, Sean Grimmond (University of Queens-
land, Australia) and colleagues reported a novel way to map
regulatory networks by surveying the transcriptional output
in a model system of ES cell differentiation. They used
transcript shotgun, cap analysis gene expression (CAGE)
and small RNA sequencing of mouse genome to determine
the activity and transcriptional complexity of the whole
genome. They subsequently identified thousands of new
protein-coding transcripts and established pathways and
genetic networks that control ES differentiation.
Defects in genome organization and nuclear architecture
are associated with various human diseases, including
cancer. Tom Misteli (National Cancer Institute, Bethesda,
USA) discussed how intranuclear chromosome positioning
is a determining factor in the formation of cancer trans-
locations. His group has developed and used an
experimental system to examine how double-strand breaks
(DSBs) are recognized in vivo and how DNA damage
response pathways are activated in the context of
chromatin. In this system, DSBs can be induced at a defined
genomic site and monitored in real time in living cells. He
presented data showing that chromosomes are organized in
nonrandom higher-order spatial locations within the
nucleus and that physical proximity of chromosomes
contributes to the formation of translocations. In line with
this interpretation, his group finds that broken
chromosome ends maintain their position and generally
only undergo translocations with neighboring DSBs.
Remarkably, using this same system, Misteli reported that
their data strongly suggest that the cellular DNA damage
response can be activated in the absence of DNA damage.
Epigenetics is the study of heritable changes in gene
expression that occur in the absence of changes in the
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Institute of Medical Research, Herston, Australia) described
a mutagenesis screen using ethylnitrosourea for modifiers of
epigenetic reprogramming in the mouse. In this screen, an
erythroid-specific green fluorescent protein (GFP) transgene
that is sensitive to perturbations in the epigenetic machinery
was used to isolate dominant mutations that varied the
expression of the GFP reporter. Several of these mutations
were confirmed to be involved in epigenetic regulation by
their ability to affect the expression of the endogenous gene
agouti viable yellow, a well-known locus with epigenetic
variability.
In conclusion, genome regulation requires coordination of
various regulatory mechanisms, including transcriptional
regulation, chromatin remodeling and nuclear organization.
By showcasing speakers from the most innovative research
groups in the field, the meeting created an electrifying
atmosphere as discoveries pivotal to modern genome biology
were reported.
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